WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 7001 Infant (under 12 months) mortality rate: 712
GDP / capita (US$): 1'9901 Child (under 5 years) mortality rate: 982

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 30'552  29'825  29'105  28'398  27'708  20'595  11'731  13'180 
Births 1'042  1'053  1'066  1'079  1'092  1'048  643  657 
Surviving infants 973  981  991  1'001  1'011  948  560  543 
Pop. less than 5 years 4'905  4'964  5'010  5'030  5'036  4'263  2'301  2'511 
Pop. less than 15 years 14'244  14'136  13'990  13'802  13'567  10'187  5'708  6'161 
Female 15-49 years 6'793  6'527  6'280  6'054  5'857  4'277  2'509  2'888 

Number of reported case

(Click for retrospective incidence data for Afghanistan)
Diphtheria 84  368  1'939 
Japanese encephalitis
Measles 430  2'787  3'013  1'989  2'861  6'532  1'609  32'455 
Mumps
Pertussis 371  1'497  896  411  15'748 
Polio* 17  46  81  30  38  120  48  880 
Rubella 367  750  46  501 
Rubella (CRS)
Tetanus (neonatal) 13  21  20  23  139  16 
Tetanus (total) 24  37  20  23  19  131  1'618 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Afghanistan)
Vaccine year result method % card seen                                                
BCG 2010  64  MICS   31  89  89  83  68  64  30  30  33 
DTP1 2010  58  MICS   31  98  99*  94  86  84  48 
DTP3 2010  40  MICS   31  90  87  82  66  63  24  25 
HepB_BD         
HepB3          90  87  82  66  63 
Hib3          90  87  82  66  63 
JapEnc         
MCV 2010  56  MICS   31  82  81  75  62  60  27  20  11 
MCV2          56  54  48  46  40 
PCV1         
PCV3         
Pol3 2010  48  MICS   31  90  87  82  66  63  24  25 
Rota1         
Rota_last         
Rubella1         
TT2plus 2011  35       63  76  75  65  68  20 
PAB         
VAD1          15 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Afghanistan)
BCG 75  75  71  68  64  30  30 
DTP1 86  86  86  86  84  48  50  22 
DTP3 71  71  68  66  63  24  25 
HepB3 71  71  68  66  63 
HepB_BD
Hib3 71  71  68  66  63 
MCV 75  68  65  62  60  27  20  11 
MCV2 40  37  31  29  24 
PAB 65  60  60  79  89  32  13 
PCV3
Pol3 71  71  68  66  63  24  25 
Rota_last

Number of districts in the country 329  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
98 
   
/
|
|
\
Greater or equal to 90% 56
From 80 to 89% 10
From 50 to 79% 24
Less than 50% 9
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
Measles 9, 18 months; Yes
OPV birth; 6, 10, 14 weeks; 9 months; Yes
Pneumo_conj 6, 10, 14 weeks; Yes From January 2014
TT 1st contact; +1, +6 months; +1, +1 year; Yes CBAW

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2010-2015  2006-2010  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 321  321  321  321  324  324   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 329  329  329  329  329  329  329 
Nº districts with DTP3 coverage >=80% number 219  195  187  190  185  191  47 
% of districts with DTP3 coverage >=80% From 0 to 100% 67  59  57  58  56  58  14 
Nº districts with measles (MCV1) coverage >=95% number 136  111  99  93  68  67   
% of districts with MCV1 coverage >=95% From 0 to 100% 41  34  30  28  21  20   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  No  No    Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100%   10 

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.